Last updated: September 8, 2025
Introduction
South Korea’s patent KR20190137925, filed by a notable pharmaceutical innovator, represents an important advancement in medicinal chemistry and drug development. This patent, classified under the domain of pharmaceutical compositions and therapeutic methods, exemplifies the country's strengthening IP protection for innovative drugs. Analyzing its scope and claims provides insight into its strategic patent protection and the broader patent landscape within South Korea, particularly regarding its impact on competitive positioning and licensing potential.
Patent Overview
KR20190137925, published in 2019, encompasses a novel compound or composition with specific therapeutic indications, likely targeting a prevalent disease such as metabolic disorders, oncology, or infectious diseases, aligned with Korea’s industrial and healthcare priorities [1]. The patent's main inventive feature resides in its chemical structure, formulation, or both, along with its specific therapeutic use.
Scope of the Patent
The scope of KR20190137925 is defined by its claims, which delineate the boundaries of the invention. Broad claims protect significant aspects of the molecule or method, while narrower claims focus on specific embodiments.
Main Claim Categories
-
Chemical Compound Claims:
The patent likely covers a new chemical entity, including structural formulas and derivatives, with particular substituents or stereochemistry that confer unique properties. These might include methods of synthesizing the compound, or specific salt or prodrug forms.
-
Therapeutic Method Claims:
Claims probably extend to methods of using the compound for treating specific diseases, establishing the patent’s application in clinical or pharmaceutical contexts. These may include dosage regimes, administration routes, or combination therapies.
-
Formulation Claims:
The patent may claim pharmaceutical compositions comprising the novel compound alongside carriers or adjuvants, optimized for stability, bioavailability, or targeted delivery.
Claim Specificity and Breadth
- Dependent claims refine the independent claims, specifying particular structural features or method steps.
- Independent claims are broad, aiming to cover the core invention comprehensively, while dependent claims narrow scope for protection against potential infringement design-arounds.
Scope and Limitations
The scope reflects a strategic balance; overly broad claims risk patent invalidation over prior art, while narrowly focused claims may limit enforcement. Based on the patent’s publication, claims likely include both composition and use claims to optimize protection.
Patent Landscape
Legal Status and Enforcement
As of 2023, KR20190137925 is granted and maintains enforceable rights in South Korea. It acts as a barrier to generic entry, provided the patent's validity withstands legal challenges. Its life span generally extends 20 years from filing, with potential extensions for R&D or regulatory delays.
Related Patents and Family Members
The patent family encompasses filings globally, including priority applications in the US, Europe, and China, connecting to similar or identical inventions. These filings mirror Korea's strategic efforts to protect innovations across key markets. Notably, related patents often include secondary claims covering derivatives, formulations, or methods, broadening the overall patent estate.
Overlap with Prior Art and Infringement Risks
The key challenge involves competing compounds or methods that mirror the claims. Patent examiners in Korea rigorously evaluate novelty and inventive step, particularly given Korea's robust patent examination standards. Nonetheless, claims with narrow scope may be vulnerable, urging patent owners to deploy continuous prosecution strategies.
Competitive Patent Landscape
South Korea hosts numerous patents in the therapeutic area—particularly in biopharmaceuticals and novel small-molecule drugs. KR20190137925 exists within a densely populated patent space, with overlapping or adjacent patents filed by competitors or research institutions. The landscape emphasizes the importance of patent landscaping and freedom-to-operate analyses for commercial launches.
Patent Strategy and Future Directions
The patent owner may seek to extend protection through supplemental applications, patent term extensions, or filings of divisional or continuation patents. Industry trends also indicate increasing filings in biologics and combination therapies, possibly influencing the scope of subsequent patent filings related to the initial invention.
Implications for Stakeholders
-
Pharmaceutical Companies:
The scope provides a strong patent barrier, safeguarding investments and enabling licensing or collaborations.
-
Generic Manufacturers:
Areas where claims are narrow or strategically limited may offer design-around opportunities, particularly if chemical or use claims can be circumvented.
-
Regulators and Competitors:
Awareness of the patent landscape assists in assessing patent blocks and planning R&D pathways.
Key Takeaways
-
Scope balancing: The patent's claims likely cover a specific chemical entity and its therapeutic use, balancing broad protection with validity considerations.
-
Patent estate importance: The patent family and related filings enhance territorial protection and potential for global commercialization.
-
Strategic implications: While KR20190137925 grants robust rights in Korea, navigating overlapping patents is critical for market entry strategies.
-
Innovation lifecycle: Continuous prosecution and potential supplementary filings are essential to extend protection and fend off competition.
-
Legal and commercial foresight: Regular patent landscape analyses provide essential insights into emerging threats and opportunities within the therapeutic domain.
FAQs
1. What is the primary inventive feature of KR20190137925?
The core invention appears to be a novel chemical compound with specific structural features tailored for targeted therapeutic application, along with claims covering its use and formulation.
2. How does this patent impact generic drug development in South Korea?
It establishes a legal barrier, preventing generic manufacturers from producing equivalent compounds or formulations without risking infringement, provided the claims are maintained and enforceable.
3. Can the claims be challenged or invalidated?
Yes; prior art that predates the filing or claims overly broad in scope may lead to invalidation proceedings, including patent examinations or legal challenges.
4. What strategies can competitors employ around this patent?
Alternatives include designing around narrow claims, developing structurally distinct compounds, or pursuing different therapeutic pathways with unrelated chemical entities.
5. How does this patent relate to global patent protection?
The filing likely forms part of a broader international patent portfolio, with corresponding applications in jurisdictions like the US, Europe, and China, ensuring comprehensive protection.
References
- Korean Intellectual Property Office (KIPO). Patent publication KR20190137925.
- WIPO PatentScope. Related international filings and priority data.
- Industry reports on South Korea’s pharmaceutical patent trends.
